STOCK TITAN

BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BioCryst Pharmaceuticals (Nasdaq: BCRX) has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Tuesday, January 14, 2025, at 6:00 p.m. ET. Interested parties can access both the live audio webcast and a replay of the presentation through the Investors & Media section on BioCryst's official website (www.biocryst.com).

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+3.96% News Effect

On the day this news was published, BCRX gained 3.96%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025, at 6:00 p.m. ET.

Link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com


FAQ

When is BioCryst (BCRX) presenting at the 2025 J.P. Morgan Healthcare Conference?

BioCryst (BCRX) is scheduled to present at the conference on Tuesday, January 14, 2025, at 6:00 p.m. ET.

How can investors access BioCryst's (BCRX) J.P. Morgan Healthcare Conference presentation?

Investors can access both the live audio webcast and replay through the Investors & Media section of BioCryst's website at www.biocryst.com.

Which annual J.P. Morgan Healthcare Conference will BCRX present at in 2025?

BioCryst will present at the 43rd Annual J.P. Morgan Healthcare Conference in 2025.

Where will the 2025 J.P. Morgan Healthcare Conference featuring BCRX take place?

The conference will take place in San Francisco.
Biocryst Pharmaceuticals Inc

NASDAQ:BCRX

BCRX Rankings

BCRX Latest News

BCRX Latest SEC Filings

BCRX Stock Data

1.67B
206.83M
1.26%
95.59%
13.09%
Drug Manufacturers - Specialty & Generic
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM